Published in Health Business Week, May 22nd, 2009
Under the terms of the agreement in principle with the staff of the SEC, Diebold will neither admit nor deny civil securities fraud charges, will pay a penalty of $25 million and agree to an injunction against...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.